As at May 20, 2022Show prices

SaskWorks Diversified (Class A - Series A) 23.9952

SaskWorks Diversified (Class A - Series B) 24.5637

SaskWorks Diversified (Class A - Series F) 27.6426

SaskWorks Resources (Class R - Series A) 20.6995

SaskWorks Resources (Class R - Series B) 22.1958

SaskWorks Resources (Class R - Series F) 20.9321

News

December 29, 2016

PFM CIO Opens Market with Cannimed

PFM CIO Opens Market with Cannimed

 

Brent Zettl, President and CEO, CanniMed Therapeutics Inc.(TSX:CMED) and Rob Duguid , Chief Investment Officer, PFM Capital Inc. joined Brady Fletcher, Managing Director, TSX Venture Exchange to open the market. CanniMed is a Canadian-based, international plant biopharmaceutical company with 15 years of pharmaceutical cannabis cultivation experience. The Company has a plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. CanniMedTherapeutics Inc., will commence trading on Toronto Stock Exchange on December 29, 2016. For more information, please visit www.cannimed.ca

View All News

Back to Top